Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 124

Results For "program"

1955 News Found

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes
News | April 12, 2023

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes

Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes


Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad
News | April 12, 2023

Mandaviya inaugurates Robotic Surgery and AI Department at Yashoda Hospital, Ghaziabad

The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament


Thermo Fisher Scientific expands its capabilities in France
News | April 10, 2023

Thermo Fisher Scientific expands its capabilities in France

Bourgoin early development hub broadens offerings for oral solid dose formulations


Virpax reports on progress of Envelta
Drug Approval | April 10, 2023

Virpax reports on progress of Envelta

Envelta is the company’s non-opioid pain product candidate for acute and chronic pain


Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023
News | April 08, 2023

Emcure Pharmaceuticals bags Merit Award at HIV Congress 2023

The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.


Todaro Robotics completes 2+ years partnership with Abwiz Bio
Medical Device | April 07, 2023

Todaro Robotics completes 2+ years partnership with Abwiz Bio

The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions


mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA
Drug Approval | April 07, 2023

mRNA-4157/V940in combination with Keytruda receives PRIME scheme designation from EMA

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial and unmet need for additional therapeutic options for certain types of melanoma


Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections
News | April 06, 2023

Microbion gets US patent for the use of inhaled pravibismane for pulmonary infections

Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039